Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
March 23, 2026
Health
-
-
SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution
March 23, 2026
-
HealthWarehouse.com Reports Full Year 2025 Results
March 20, 2026
-
Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia
March 20, 2026
-
OneMedNet and Navidence Announce Strategic Collaboration: Empowering Pharma with Precision Real-World Data Insights
March 18, 2026
-
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity
March 18, 2026
-
Cumberland Pharmaceuticals Launches New Sancuso® Website Featuring Educational Resources for Chemotherapy-Induced Nausea and Vomiting
March 17, 2026
-
Flyte Launches Florida Hops to Service Accelerating Demand
March 16, 2026
-
Vicarious Surgical Announces Strategic Plan to Pursue Nasdaq Listing
March 16, 2026
-
NEXGEL Announces Consideration Terms of Agreement to License and Acquire Portfolio of Commercial-Stage Regenerative Biomaterial Products
March 12, 2026
-
Trinity Biotech Begins Rollout of Innovative Glucose Monitoring System In Key Market Following Regulatory Approval of Next-Generation Premier Hb9210 HbA1c Column System
March 12, 2026
-
WallachBeth Capital Announces Closing of Tenon Medical, Inc Private Placement of Senior Original Issue Discount Convertible Notes Offering for Gross Proceeds of $4.3 Million
March 12, 2026
-
Catheter Precision, Inc. Secures up to $88 Million in Strategic Institutional Financing Commitments to Fund Accelerated Growth
March 11, 2026
-
Allurion Begins Training and On‑Boarding of U.S. Accounts, Marking Major Milestone in Expansion Strategy
March 11, 2026
-
NEXGEL Signs Definitive Agreement to License and Acquire Transformative Portfolio of Commercial-Stage Regenerative Biomaterial Products
March 10, 2026
-
Biofrontera Inc. Reports Positive Phase 2b Results Supporting Further Development of Ameluz® Photodynamic Therapy for moderate to severe Acne Vulgaris
March 9, 2026